I've read that preventing a second stroke is very important. Currently the Oregon Stroke Center is involved in two exciting stroke prevention clinical trials. Approximately 4200 patients at multiple centers in North America and Europe will participate, and the Oregon Stroke Center is one of these centers.
High cholesterol is thought to be a risk factor for stroke.
This drug has been shown to reduce LDL cholesterol in both patients with high cholesterol and normal volunteers. Elevated blood levels of LDL cholesterol may contribute to hardening of the arteries in the brain or the heart and increase the risk of stroke or heart attack. Patients who qualify for this study must be 18 years or older, must have experienced a stroke or TIA within 1 to 6 months prior starting the study drug, have no history of coronary artery disease, have no atrial fibrillation, and cannot have a severe coexisting disease. Researchers have found that high homocysteine levels can increase the risk of stroke. For this study, participants will take either low or high doses of B vitamins daily for two years.